News

The COAST-X clinical trial program is evaluating ixekizumab across various population subsets of patients with axial spondyloarthritis.
Top news of the day from across the health care landscape.
Top news of the week from Specialty Pharmacy Times.
An analysis showed increasing rates of medical marijuana use for individuals diagnosed with cancer over a 10-year period.
Investigators used a CRISPR technique to expose weaknesses in the acute myeloid leukemia enzyme that many drugs target.
Announcement positions specialty pharmacy group for continued growth.
Top news of the day from across the health care landscape.

Most Popular

Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$